Shanghai Upper Bio-tech Pharma Co., Ltd has quoted to transfer 5.2 percent of its equities for a base price of 30.52 million yuan on the Shanghai United Assets and Equity Exchange (UAE).
With a registered capital of 45.91 million yuan, Shanghai Upper Bio-tech Pharma Co., Ltd boards expertise in research and development, technical consultation and technical transformation in the professional fields of medical equipment, biological products and diagnostic reagent.
According to a company filing, the company achieved net profit of 20.83 million yuan in 2014 and its operating turnover reached 98.87 million yuan.
Latest comments